NRC Health Long-Term Debt
NRC Health (NRC) had Long-Term Debt of $86.01 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-04
- 2026-06-30: Long-term Debt, Excluding Current Maturities $86.01M.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $74.02M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $75.02M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $76.03M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2026-06-30 | $86.01M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $74.02M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $75.02M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $76.03M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $77.03M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $58.67M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $57.90M 10-K · filed 2026-03-05 |
| 2024-09-30 | $44.91M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $25.66M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $27.57M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $29.47M 10-K · filed 2025-03-17 |
| 2021-03-31 | $25.49M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $26.55M 10-Q · filed 2021-05-07 |
| 2020-09-30 | $27.58M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $28.63M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $28.59M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $29.80M 10-K · filed 2021-03-05 |
| 2019-09-30 | $30.98M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $32.14M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $33.22M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $34.18M 10-K · filed 2020-03-06 |
| 2018-09-30 | $35.11M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $36.03M 10-Q · filed 2018-08-09 |
| 2016-12-31 | $857.00K 10-K · filed 2018-03-14 |
| 2015-12-31 | $3.34M 10-K · filed 2017-03-03 |
| 2014-12-31 | $5.74M 10-K · filed 2016-03-04 |
| 2013-12-31 | $8.07M 10-K · filed 2015-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |